Description

Corvalazid (ethyl ether of α-bromisovaleric acid, phenobarbital) oral drops 25 ml. vial

Ingredients

Active ingredients: ethyl ether of α-bromisovaleric acid, phenobarbital.

Dosage

Recommended dosage: Consult your healthcare provider for the appropriate dosage based on your condition.

Indications

Corvalazid oral drops are indicated for the relief of anxiety and tension.

Contraindications

Do not use Corvalazid oral drops if you are allergic to any of the ingredients or have a history of substance abuse.

Directions

Shake well before use. Take the prescribed amount orally, as directed by your healthcare provider.

Scientific Evidence

Corvalazid combines the anxiolytic properties of ethyl ether of α-bromisovaleric acid with the sedative effects of phenobarbital, providing a synergistic action in managing anxiety disorders. Studies have shown that this combination therapy can effectively reduce symptoms of anxiety and promote relaxation.

Additional Information

It is important to follow the prescribed dosage and not exceed the recommended amount to avoid potential side effects. If you experience any adverse reactions, discontinue use and consult your healthcare provider.

Clinical trials have demonstrated the efficacy of Corvalazid in improving symptoms of anxiety compared to placebo, highlighting its role as a valuable treatment option for individuals suffering from anxiety disorders.